Stay updated on Olaptesed with Pembrolizumab in Colorectal and Pancreatic Clinical Trial
Sign up to get notified when there's something new on the Olaptesed with Pembrolizumab in Colorectal and Pancreatic Clinical Trial page.

Latest updates to the Olaptesed with Pembrolizumab in Colorectal and Pancreatic Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe page revision label was updated to v3.6.3, replacing the previous v3.6.2. This appears to be a minor maintenance update and does not alter study details.SummaryDifference0.1%

- Check15 days agoChange DetectedRevision tag updated to v3.6.2, replacing v3.6.0, signaling a minor page update. The core study details and data on the page appear unchanged.SummaryDifference0.1%

- Check29 days agoChange DetectedA recruitment-closed notice has been added, and new help sections such as 'How to Read a Study Record' and 'How to Join a Study' have been introduced to assist visitors.SummaryDifference0.5%

- Check37 days agoChange DetectedThe page revision was updated from v3.5.4 to v3.5.5, signaling a minor administrative update to the study record metadata. No substantive content, criteria, or results have changed.SummaryDifference0.1%

- Check58 days agoChange DetectedA new revision label, Revision: v3.5.4, was added to the page, replacing the previous revision tag. This indicates a software/identity update to the site rather than a change to the study content or data.SummaryDifference0.1%

- Check80 days agoChange DetectedThe page’s footer revision/version indicator was updated from v3.5.2 to v3.5.3, reflecting a site software release rather than any change to the clinical trial record content.SummaryDifference0.1%

Stay in the know with updates to Olaptesed with Pembrolizumab in Colorectal and Pancreatic Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Olaptesed with Pembrolizumab in Colorectal and Pancreatic Clinical Trial page.